The trial, run by The Montreal Heart Institute says “The main aim of this study is to determine the effects of short-term treatment with hesperidin on COVID-19 symptoms in comparison with a placebo.” The release says the “treatment effects will be observed through a symptoms diary that will be completed by participants throughout the study and by taking the oral temperature daily.”
Bringing You The Stories That Matter.
You must be logged in to post a comment.